Institutional Research
For Cancer Centers & Research Teams
CS Cancer Solutions is an operating public-source oncology research-intelligence platform that makes public research evidence easier to find, connect, and assess across cancer types, biomarkers, therapies, clinical trials, publications, and reported outcomes. Additional institutional engagements and analytics are being explored. We are speaking with oncology researchers and institutional teams to identify the most useful first application.
Oncology evidence is spread across publications, trial registries, biomarker studies, and institutional research programs. Teams examining one cancer or research question may need to reconcile different study populations, endpoints, evidence maturity, and reported outcomes. CS Cancer Solutions makes these relationships easier to explore while keeping original sources and limitations visible.
Explore Current Resources
These resources are accessible on the platform today. Each is described as research information or educational context; coverage varies and is expanding.
Ocular (Uveal) Melanoma Module
The platform's rare-cancer evidence-summary module, presenting research context for this uncommon cancer type. It is currently the only live module; coverage of other cancer types is in development.
View ResourceA–Z Cancer Types Directory
Educational information about cancer types, including definitions, symptoms, risk factors, and reference material. It is general educational context, not treatment guidance.
View ResourceClinical Trial Registry Information
Information about clinical trials drawn from public trial registries, browsable by region. Coverage is partial and some records are incomplete; the listings are research information, not trial matching or eligibility assessment.
View ResourceBiomarker Research Library
Educational and research context on cancer biomarkers — what they are, associated cancer types, and research directions. It is informational, not diagnostic or therapeutic guidance.
View ResourceSpecialist Directory
Directory listings of oncology specialists compiled from public institutional sources, with verification-status labels. These are listings for research and information — not referrals or recommendations.
View ResourceCancer Center Listings
Listings of cancer centers, hospitals, and research institutes with public program information. Inclusion is informational and does not imply endorsement or ranking.
View ResourceWhat We Hope to Test With Institutions
These questions guide our conversations with oncology researchers and institutional teams.
How research teams currently find and reconcile relevant oncology evidence — and whether linked research, trial, biomarker, and publication context would help them locate it.
Where trial, biomarker, publication, and outcome sources remain disconnected, and how researchers and research operations staff currently identify gaps across them.
Which source details, study limitations, update dates, and other evidence context must be visible for a summary to be useful and trusted.
Whether a focused rare-cancer research summary would be useful, and which research questions would benefit from concise, dated summaries with links to original sources.
Ocular (uveal) melanoma is one possible starting domain for a focused institutional research pilot, subject to what customer interviews reveal.
A future pilot could focus on one oncology research question, one participating team, an agreed set of public sources, and a defined review period. Its scope and measures would be developed with the participating institution. A pilot is being explored; it is not currently offered as a standard 30-day program.
What CS Cancer Solutions Is Not
CS Cancer Solutions is intended for research and educational context. It does not provide patient-specific advice, treatment recommendations, clinical decision support, patient navigation, or integration with medical records. Do not submit patient information through this page.
Share how your team currently works with oncology evidence and what a useful first application might look like.
Please do not include patient information, protected health information, or identifiable case details in this form.